← Tra cứu cổ phiếu

iShareInvest Research

HOSE · Quý 2/2026

TCM

Dệt may - Đầu tư - Thương mại Thành Công

Analysis of business results & financial statements · Quý 2/2026

▼▼ Declining sharply

Trailing net profit reached 220.2bn, fell 81.6bn compared with the same period last year. Key positives came from lower tax and lower finance costs. Offsetting pressure came mainly from lower gross profit, lower financial income, and higher administrative expenses. Detailed impact is shown below:

See what is changing ↓
P/E
7.79x
P/B
0.72x
EPS
1,887
BVPS
20,520
ROE
9.3%
ROA
5.2%
Market price
14,700
16 Oct 2026

What Is Changing

On a TTM 2026Q2 basis, TCM is going through a period of clear decline across multiple metrics at once — profit momentum has been slowing across consecutive periods. What still needs to be determined is whether the business can find a stabilization point in the near term, or whether current pressure has not yet run its course.

Profit bridge

Vs last year · TTM

  1. Tax
  2. Finance costs
  3. Gross profit
  4. Financial income
  5. Administrative expenses
  6. Other
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue968.11,010.1858.1902.4873.01,010.9925.01,104.6
LNST45.865.946.764.082.078.661.781.5
Net margin4.74%6.52%5.45%7.10%9.39%7.77%6.67%7.38%

Revenue

968bn

Net income

46bn

Net margin

4.74%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

Revenue Growth

●

Is growth real and durable?

Trailing-12-month revenue declined 4.5% year on year — not from a single spike: quarterly growth stepped up from −18% to +11%.

1 of the last 4 quarters grew year on year.

Revenue TTM
3,739bn
−4.5%
Latest quarter YoY
+11%
accelerating

What is driving the margin?

▼

Net margin fell to 5.95%, losing 1.8pp. The main pressure comes from Gross margin fell 1.4pp and SG&A / Revenue rose 0.8pp (with lingering pressure from Other profit / Revenue fell 0.1pp).

The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.

Net Margin
5.95%
−1.8pp
Gross Margin
14.75%
−1.4pp
SG&A / Revenue
7.91%
+0.8pp

TTM YoY · 2025Q2 -> 2026Q2

Cash Flow

▲▲

Is profit converting into cash?

With leverage safe, cash flow shows the self-funding capacity. Operating cash flow reached 235.0bn against investing cash flow of -25.4bn (annual cash-flow figures for 2025).

Post-investment cash flow was positive +209.5bn. Financing cash flow was positive +42.1bn.

CFO / net income was 2,10 lần.

After spending +241.3bn on fixed-asset investment, the business generated trailing free cash flow of +221.5bn.

Earnings Quality

▲

How much income is non-core?

About 92% of pre-tax profit comes from core operations.

Within that, net financial result at +6.7%, other profit at +1.1% of PBT.

Non-core / PBT
7.8%
low
Net financial / PBT
6.7%
Other profit / PBT
1.1%
02

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

▼▼

ROIC fell to 8.12%, losing 3.8pp. That translates to 8.12 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin narrowed 1.9pp and capital turnover fell 0.15x, while invested capital rose by 152bn — pressure came from both operational efficiency and asset efficiency.

Pressure came from the margin side — core operations are weakening, not just a temporary asset-management issue.

Working Capital Efficiency

▼

Cash conversion cycle lengthened by 11.7 days versus the same period last year. The main moves came from DIO rose 3.1 days, DSO rose 9.0 days, and DPO rose 0.4 days.

Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.

Cash conversion cycle remains stretched

CCC stands at 128.6 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +9.0 days, pointing to slower receivables turnover.

DuPont

What drives ROE?

Net margin 6.0% -1.8pp
Asset turnover 0.89x -0.11x
Financial leverage 1.77x +0.02x
ROE 9.4% -4.2pp

ROE fell from 13.6% to 9.4% — net margin weakened the most, though leverage still provided support.

03

Is financial risk significant?

Financial risk is low — leverage is safe, both CFO and FCF are positive.

Leverage & Liquidity

▲

Leverage looks fairly comfortable, with net debt / equity at 0.11x and interest coverage at 4.97x.

At present, short-term debt accounts for 84.8% of total debt, cash equals 72.1% of debt, and total debt stands at 959.9bn.

Net Debt / Equity
0.11x
−0.04x
Interest Coverage
4.97x
−0.30x
Cash / Debt
72.1%
+7.0pp
Short-term Debt / Total Debt
84.8%
−1.2pp

TTM YoY · 2025Q2 -> 2026Q2

Short-term refinancing pressure is meaningful

Short-term debt accounts for 84.8% of total debt, raising near-term refinancing needs.

Balance Sheet

▲

The balance sheet shows capital-allocation efficiency slipping. Capital structure is conservative with low leverage — liabilities at 0.70x equity, net debt at 0.11x equity.

Inventory ended the period at 987.3bn, roughly 23.7% of total assets.

Over the last 12 months, working capital released 190.5bn of cash, mainly thanks to lower receivables and higher payables. Pressure from higher inventories only partly offset that benefit.

Research synthesis

What this reporting period is showing

The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. The brighter spot is earnings conversion is confirmed, with CFO/NI at 2.10x. The main risk still sits in core profitability, with net margin down 1.8 pp.

  • Improvement: earnings conversion looks more confirmed, with CFO / net income at 2.10x.
  • Key risk: profitability remains under pressure, with trailing-12M net margin at 5.95% after a 1.8pp decline versus the same period last year.

Questions for the next period

  1. Whether revenue stabilizes after a −4,5% YoY decline or keeps falling.

  2. Whether margins hold around the current 5.95% level or narrow again.

  3. Whether operating cash flow holds its 235.0bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio